PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, is pleased to announce data presentations in support of its preclinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback